Dyskeratosis congenita: a literature review

Dyskeratosis congenita is a rare hereditary disease that occurs predominantly in males and manifests clinically as the classic triad of reticulate hyperpigmentation, nail dystrophy and leukoplakia. It increases the risk of malignancy and other potentially lethal complications such as bone marrow failure, lung and liver diseases. Mutations in 19 genes are associated with dyskeratosis congenita, and a fifth of the pathogenic mutations are found in DKC1, the gene coding for dyskerin. This review aims to address the clinical and genetic aspects of the disease.

[1]  Sicong Zeng,et al.  Telomerase insufficiency induced telomere erosion accumulation in successive generations in dyskeratosis congenita family , 2019, Molecular genetics & genomic medicine.

[2]  Y. Akagi,et al.  Development of metachronous rectal cancers in a young man with dyskeratosis congenita: a case report , 2019, Journal of Medical Case Reports.

[3]  J. Fitzgibbon,et al.  Homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita-like phenotypes. , 2018, Blood.

[4]  S. Savage,et al.  Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita. , 2018, Blood advances.

[5]  V. Dissanayake,et al.  Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report , 2018, BMC Medical Genetics.

[6]  Decheng Cai,et al.  A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita , 2018, Medicine.

[7]  S. Feng,et al.  A unique homozygous WRAP53 Arg298Trp mutation underlies dyskeratosis congenita in a Chinese Han family , 2018, BMC Medical Genetics.

[8]  P. Rosenberg,et al.  Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita , 2017, Journal of the American Academy of Dermatology.

[9]  A. Mondino,et al.  Clinical heterogeneity in a family with DKC1 mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins , 2017, Pediatric reports.

[10]  A. Barwad,et al.  Cytomegalovirus Retinitis as a Presenting Feature of Multisystem Disorder: Dyskeratosis Congenita , 2017, Middle East African journal of ophthalmology.

[11]  W. Fok,et al.  p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita , 2017, Stem cell reports.

[12]  G. Raghu,et al.  Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders , 2017, European Respiratory Journal.

[13]  U. Desai,et al.  Dyskeratosis Congenita Associated Non-Specific Interstitial Pneumonia , 2017 .

[14]  T. Mine,et al.  Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita , 2016, Internal medicine.

[15]  S. Tripathi,et al.  Dyskeratosis congenita presenting with dysphagia , 2016, Indian Dermatology Online Journal.

[16]  K. Myers,et al.  A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  Sijia Li,et al.  Frosted Branch Angiitis in Pediatric Dyskeratosis Congenita , 2016, Medicine.

[18]  S. Kilic,et al.  Juvenile Idiopathic Inflammatory Myopathy in a Patient With Dyskeratosis Congenita Due to C16orf57 Mutation , 2016, Journal of pediatric hematology/oncology.

[19]  T. Brümmendorf,et al.  DNA methylation in PRDM8 is indicative for dyskeratosis congenita , 2016, Oncotarget.

[20]  F. Goldman,et al.  Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells , 2016, PloS one.

[21]  F. Ozkinay,et al.  A case of dyskeratosis congenita associated with hypothyroidism and hypogonadism , 2015, Hormones.

[22]  M. Lal,et al.  Avascular Necrosis of Head of Femur in Dyskeratosis Congenita - A Rare Presentation , 2016, Indian Journal of Hematology and Blood Transfusion.

[23]  B. Zlateska,et al.  Treatment of dyskeratosis congenita‐associated pulmonary fibrosis with danazol , 2015, Pediatric pulmonology.

[24]  V. Pamecha,et al.  Liver Transplantation After Bone Marrow Transplantation for End Stage Liver Disease with Severe Hepatopulmonary Syndrome in Dyskeratosis Congenita: A Literature First. , 2015, Journal of clinical and experimental hepatology.

[25]  T. Rausch,et al.  A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition , 2015, Aging.

[26]  T. Limjindaporn,et al.  Novel Mutation of the TINF2 Gene in a Patient with Dyskeratosis Congenita , 2015, Case Reports in Dermatology.

[27]  H. Tummala,et al.  Long tails, short telomeres: Dyskeratosis congenita , 2015, Oncotarget.

[28]  D. French,et al.  Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients , 2015, PloS one.

[29]  M. Tandon,et al.  Dyskeratosis congenita induced cirrhosis for liver transplantation-perioperative management , 2015, Indian journal of anaesthesia.

[30]  F. Iraji,et al.  Dyskeratosis Congenita Without Oral Involvement: A Rare Hereditary Disease. , 2015, Oman medical journal.

[31]  V. Plagnol,et al.  Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. , 2015, The Journal of clinical investigation.

[32]  B. Shiferaw,et al.  A Case Report on a Rare Disease: Dyskeratosis Congenita , 2015, Journal of clinical medicine research.

[33]  J. D'Orazio,et al.  Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy , 2014, Pediatric blood & cancer.

[34]  F. Pallardó,et al.  Expression of the Genetic Suppressor Element 24.2 (GSE24.2) Decreases DNA Damage and Oxidative Stress in X-Linked Dyskeratosis Congenita Cells , 2014, PloS one.

[35]  K. Sullivan,et al.  Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita. , 2014, Journal of pediatric hematology/oncology.

[36]  S. Savage,et al.  Response to androgen therapy in patients with dyskeratosis congenita , 2014, British journal of haematology.

[37]  I. Dokal,et al.  X‐linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora , 2014, Clinical and experimental dermatology.

[38]  A. Ibrahim,et al.  Dyskeratosis congenita in a Nigerian boy , 2014, Nigerian medical journal : journal of the Nigeria Medical Association.

[39]  S. Kapoor Kindler syndrome: a close mimic of dyskeratosis congenita and the need to distinguish the two clinical entities. , 2014, Oman Medical Journal.

[40]  M. Gleeson,et al.  Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post‐hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation , 2014, Pediatric transplantation.

[41]  B. Thapa,et al.  Malrotation of Gut and Hiatus Hernia in a Child with Familial Dyskeratosis Congenita. , 2014 .

[42]  Gobinda Mondal,et al.  Dyskeratosis congenita: a rare case report , 2013 .

[43]  A. Bertuch,et al.  Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. , 2013, Translational research : the journal of laboratory and clinical medicine.

[44]  A. Auerbach,et al.  Telomere Phenotypes in Females with Heterozygous Mutations in the Dyskeratosis Congenita 1 (DKC1) Gene , 2013, Human mutation.

[45]  T. Patel,et al.  DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita , 2013, PloS one.

[46]  J. Teruya-Feldstein,et al.  Posttransplant Lymphoproliferative Disorder Complicating Hematopoietic Stem Cell Transplantation in a Patient With Dyskeratosis Congenita , 2013, International journal of surgical pathology.

[47]  M. Schiffman,et al.  Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: A search for human papillomavirus , 2013, International journal of cancer.

[48]  T. Vulliamy,et al.  Haematological recovery in dyskeratosis congenita patients treated with danazol , 2013, British journal of haematology.

[49]  M. Arshad,et al.  Dyskeratosis Congenita: A Report of Two Cases , 2013, Case reports in dentistry.

[50]  P. Rosenberg,et al.  Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[51]  H. Ochs,et al.  Common variable immunodeficiency as the initial presentation of dyskeratosis congenita. , 2013, Journal of Allergy and Clinical Immunology.

[52]  V. Trivedi,et al.  Dyskeratosis congenita- management and review of complications: a case report. , 2013, Oman medical journal.

[53]  G. Mufti,et al.  Bilateral Retinal Vasculopathy Associated with Autosomal Dominant Dyskeratosis Congenita , 2013, European Journal of Ophthalmology.

[54]  M. Aljurf,et al.  Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure , 2013, Bone Marrow Transplantation.

[55]  V. Plagnol,et al.  Constitutional Mutations in RTEL1 Cause Severe Dyskeratosis Congenita , 2013, American journal of human genetics.

[56]  K. Shin,et al.  Interstitial Lung Disease in a Patient with Dyskeratosis Congenita , 2013, Tuberculosis and respiratory diseases.

[57]  K. Jacobs,et al.  Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita , 2013, Human Genetics.

[58]  M. Gleeson,et al.  Retinal vasculopathy in autosomal dominant dyskeratosis congenita due to TINF2 mutation , 2012, British journal of haematology.

[59]  R. Mahfouz,et al.  A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita , 2012, Bone Marrow Transplantation.

[60]  Rachel B. Keller,et al.  CTC1 Mutations in a patient with dyskeratosis congenita , 2012, Pediatric blood & cancer.

[61]  J. de Villartay,et al.  [Dyskeratosis congenita: short telomeres are not the rule]. , 2012, Medecine sciences : M/S.

[62]  S. Savage,et al.  Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology? , 2012, Psychosomatics.

[63]  A. Bertuch,et al.  Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood , 2012, Clinical genetics.

[64]  Jonathan E. Dickerson,et al.  Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus , 2012, Nature Genetics.

[65]  P. Rosenberg,et al.  Telomere Length Is Associated with Disease Severity and Declines with Age in Dyskeratosis Congenita Early Release Paper Telomere Length Is Associated with Disease Severity and Declines with Age in Dyskeratosis Congenita , 2022 .

[66]  F. Shebl,et al.  The relationship between DNA methylation and telomere length in dyskeratosis congenita , 2012, Aging cell.

[67]  S. K. Pal,et al.  A CASE OF DYSKERATOSIS CONGENITA WITH PRIMARY AMENORRHEA AND ADENOCARCINOMA OF STOMACH , 2011, Indian Journal of Dermatology.

[68]  T. Kay,et al.  Dyskeratosis Congenita—Two Siblings with a New Missense Mutation in the DKC1 Gene , 2011, Pediatric dermatology.

[69]  S. Savage,et al.  Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review , 2011, BMC blood disorders.

[70]  K. Sullivan,et al.  Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum – a single‐center pediatric experience , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[71]  S. Chao,et al.  Naevus anaemicus‐like hypopigmented macules in dyskeratosis congenita , 2011, The Australasian journal of dermatology.

[72]  T. Vulliamy,et al.  Dyskeratosis congenita and the DNA damage response , 2011, British journal of haematology.

[73]  M. Bessler,et al.  Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment , 2011, Aging cell.

[74]  Richa,et al.  Dyskeratosis congenita with malignant transformation , 2011, BMJ Case Reports.

[75]  S. Kojima,et al.  Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita , 2010, Pediatric transplantation.

[76]  J. Tolar,et al.  Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita , 2011, Bone Marrow Transplantation.

[77]  B. Dörken,et al.  Reduced-Intensity Conditioning Using Fludarabine and Antithymocyte Globulin Alone Allows Stable Engraftment in a Patient with Dyskeratosis Congenita , 2010, Acta Haematologica.

[78]  C. Bellodi,et al.  Deregulation of oncogene‐induced senescence and p53 translational control in X‐linked dyskeratosis congenita , 2010, The EMBO journal.

[79]  F. Patel,et al.  Quadruple malignancy in a single patient: a case report and comprehensive review of literature. , 2010, Journal of cancer research and therapeutics.

[80]  A. Joe,et al.  A case of laryngeal carcinoma in a young adult with dyskeratosis congenita , 2010, International Journal of Clinical Oncology.

[81]  S. Savage,et al.  Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. , 2010, Ophthalmology.

[82]  P. Lansdorp,et al.  Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC , 2010, Experimental dermatology.

[83]  R. Nalçaci,et al.  Dyskeratosis congenita: clinical report and review of the literature. , 2010, International journal of dental hygiene.

[84]  J. Pulido,et al.  Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita , 2009, Ophthalmic genetics.

[85]  M. Thornhill,et al.  Dyskeratosis congenita: a case report. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[86]  P. Rosenberg,et al.  Cancer in dyskeratosis congenita. , 2009, Blood.

[87]  T. Vulliamy,et al.  An atypical form of dyskeratosis congenita with renal agenesis and no mutation in DKC1, TERC and TERT genes , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[88]  I. Dokal,et al.  Advances in the understanding of dyskeratosis congenita , 2009, British journal of haematology.

[89]  A. Boueiz,et al.  Fatal bilateral pneumothoraces complicating dyskeratosis congenita: a case report , 2009, Journal of medical case reports.

[90]  T. Vulliamy,et al.  Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients , 2009, British journal of haematology.

[91]  S. Lourenço,et al.  Dyskeratosis Congenita – Report of a Case with Emphasis on Gingival Aspects , 2009, Pediatric dermatology.

[92]  G. Elçin,et al.  Dyskeratosis congenita: report of two cases with distinct clinical presentations. , 2008, The Turkish journal of pediatrics.

[93]  T. Vulliamy,et al.  TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes , 2008, Blood.

[94]  B. Kloeckener-Gruissem,et al.  Late manifestation of dyskeratosis congenita presenting as chronic dermal ulcer in a 37‐year‐old man , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[95]  N. Giri,et al.  Oral and dental phenotype of dyskeratosis congenita. , 2008, Oral diseases.

[96]  T. Vulliamy,et al.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita , 2008, Proceedings of the National Academy of Sciences.

[97]  G. Baerlocher,et al.  Dyskeratosis congenita , 2008, British journal of haematology.

[98]  Coralie Hoareau-Aveilla,et al.  La dyskératose congénitale - Une maladie méconnue due à un maintien défectueux des télomères , 2008 .

[99]  M. Gönül,et al.  A case of dyskeratosis congenita with Chiari 1 malformation, absence of inferior vena cava, webbed neck, and low posterior hair neck , 2008, International journal of dermatology.

[100]  H. Du,et al.  Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. , 2008, Blood.

[101]  I. Dokal,et al.  Dyskeratosis congenita: a genetic disorder of many faces , 2007, Clinical genetics.

[102]  T. Vulliamy,et al.  Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. , 2007, Blood.

[103]  邓伟平,et al.  Dyskeratosis congenita , 2007 .

[104]  N. Giri,et al.  Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony‐stimulating factor , 2007, British journal of haematology.

[105]  J. de la Fuente,et al.  Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation , 2007, Pediatric transplantation.

[106]  I. Dokal,et al.  Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan , 2007, Bone Marrow Transplantation.

[107]  P. Lansdorp,et al.  Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts , 2007, Aging cell.

[108]  P. Prakash,et al.  Scytalidium infection associated with dyskeratosis congenita , 2007, The British journal of dermatology.

[109]  B. Dallapiccola,et al.  Delayed diagnosis of dyskeratosis congenita in a 40‐year‐old woman with multiple head and neck squamous cell carcinomas , 2007, The British journal of dermatology.

[110]  I. Febrer,et al.  A case of dyskeratosis congenita associated with schizophrenia and two malignancies , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[111]  J. Fournet,et al.  Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen , 2005, Bone Marrow Transplantation.

[112]  H. Kanegane,et al.  Identification of DKC1 gene mutations in Japanese patients with X‐linked dyskeratosis congenita , 2005, British journal of haematology.

[113]  W. Tom,et al.  Dyskeratosis Congenita in an Adolescent Girl with Associated Choanal Atresia , 2005, Pediatric dermatology.

[114]  E. Guinan,et al.  Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[115]  P. Tu,et al.  Identification of a novel mutation and a de novo mutation in DKC1 in two Chinese pedigrees with Dyskeratosis congenita. , 2004, The Journal of investigative dermatology.

[116]  J. Shay,et al.  Telomeres in dyskeratosis congenita , 2004, Nature Genetics.

[117]  T. Vulliamy,et al.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.

[118]  H. Ozturk,et al.  Pulmonary involvement in a patient with dyskeratosis congenita , 2003, Pediatrics international : official journal of the Japan Pediatric Society.

[119]  P. Lansdorp,et al.  Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA , 2003, The Lancet.

[120]  A. Verloes,et al.  Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome) , 2003, European Journal of Pediatrics.

[121]  A. Akar,et al.  Dyskeratosis congenita with esophageal and anal stricture , 2003, International journal of dermatology.

[122]  C. Baykal,et al.  Dyskeratosis congenita associated with three malignancies , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[123]  R. Storb,et al.  Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita , 2003, Bone Marrow Transplantation.

[124]  S. Perrotta,et al.  Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine‐based reduced‐intensity conditioning regimen , 2002, British journal of haematology.

[125]  T. Vulliamy,et al.  Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice , 2002, Oncogene.

[126]  B. Ünal,et al.  Dyskeratosis congenita with isolated neutropenia and granulocyte colony‐stimulating factor treatment , 2002, International journal of dermatology.

[127]  H. Hiramatsu,et al.  A NOVEL MISSENSE MUTATION IN THE DKC1 GENE IN A JAPANESE FAMILY WITH X-LINKED DYSKERATOSIS CONGENITA , 2002, Pediatric hematology and oncology.

[128]  P. Frossard,et al.  X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation , 2001, Thorax.

[129]  T. Vulliamy,et al.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita , 2001, Nature.

[130]  I. Dokal The Inherited Bone Marrow Failure Syndromes: Fanconi Anemia, Dyskeratosis Congenita and Diamond‐Blackfan Anemia , 2000 .

[131]  S. Moretti,et al.  Oral carcinoma in a young man: a case of dyskeratosis congenita , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.

[132]  A. Poustka,et al.  Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal‐Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1 , 1999, British journal of haematology.

[133]  Yun-Fai Chris Lau,et al.  BONE MARROW TRANSPLANT FOR DYSKERATOSIS CONGENITA , 1999, British journal of haematology.

[134]  G. Ghahremani,et al.  Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation , 1999, Bone Marrow Transplantation.

[135]  H. Esperou,et al.  Unusual complications after bone marrow transplantation for dyskeratosis congenita , 1998, British journal of haematology.

[136]  J. Goldman,et al.  Chromosomal breakage analysis in dyskeratosis congenita peripheral blood lymphocytes , 1998, British journal of haematology.

[137]  B. Belohradsky,et al.  Dyskeratosis Congenita: Multisystemic Disorder with Special Consideration of Immunologic Aspects , 1998, Clinical pediatrics.

[138]  P. Tamaro,et al.  DYSKERATOSIS CONGENITA: A CASE WITH EARLY ONSET , 1997, Pediatric dermatology.

[139]  T. Shimizu,et al.  Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation , 1997, Bone Marrow Transplantation.

[140]  P. Yesudian,et al.  Atypical dyskeratosis congenita. , 1997, Indian Journal of Dermatology, Venereology and Leprology.

[141]  C. Ho,et al.  DYSKERATOSIS CONGENITA IN AN ETHNIC CHINESE GIRL , 1996, International journal of dermatology.

[142]  G. Forni,et al.  Dyskeratosis congenita: unusual presenting features within a kindred. , 1993, Pediatric hematology and oncology.

[143]  R. Phillips,et al.  Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation , 1992, The British journal of dermatology.

[144]  M. Reichel,et al.  Dyskeratosis Congenita Associated with Elevated Fetal Hemoglobin, X‐Linked Ocular Albinism, and Juvenile‐Onset Diabetes Mellitus , 1992, Pediatric dermatology.

[145]  A. Chong,et al.  T cell immunodeficiency in dyskeratosis congenita. , 1992, Archives of disease in childhood.

[146]  M. Cristóbal‐Gil,et al.  Cytogenetic abnormalities in dyskeratosis congenita—report of five cases , 1988, Clinical and experimental dermatology.

[147]  M. Koh,et al.  Dyskeratosis congenita in two male cousins. , 1987, The British journal of oral & maxillofacial surgery.

[148]  S. Devereux,et al.  Dyskeratosis congenita with pancytopenia , 1985, Clinical and experimental dermatology.

[149]  R. Womer,et al.  Dyskeratosis congenita: two examples of this multisystem disorder. , 1983, Pediatrics.

[150]  J. Connor,et al.  Dyskeratosis congenita. Report of a large kindred , 1981, The British journal of dermatology.

[151]  R. Verwilghen,et al.  Thrombocytopenia: first symptom in a patient with dyskeratosis congenita. , 1981, Pediatrics.

[152]  P. Kinmont,et al.  (5) Dyskeratosis congenita , 1978 .

[153]  A. Trowbridge,et al.  Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature. , 1975, Journal of medical genetics.

[154]  H. Cannell Dyskeratosis congenita. , 1971, The British journal of oral surgery.